Searching for cellular targets of novel pteridines downstream of cAMP PDE inhibition

Int J Clin Pharmacol Ther. 2005 Dec;43(12):607-8. doi: 10.5414/cpp43607.

Authors

S Vatter¹, K H Merz, G Eisenbrand

Affiliation

¹ Department of Chemistry, Division of Food Chemistry and Environmental Toxicology, University of Kaiserslautern, Germany.

PMID: 16372537
DOI: 10.5414/cpp43607

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
3',5'-Cyclic-AMP Phosphodiesterases / metabolism
Antineoplastic Agents / pharmacology*
Cell Line, Tumor
Cell Proliferation / drug effects
Humans
Mitogen-Activated Protein Kinase 1 / metabolism
Mitogen-Activated Protein Kinase 3 / metabolism
Pteridines / pharmacology*

Substances

Antineoplastic Agents
Pteridines
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
3',5'-Cyclic-AMP Phosphodiesterases